The diagnostic accuracy of two methods for E6&7 mRNA detection in women with minor cytological abnormalities

Acta Obstetricia et Gynecologica Scandinavica

Volumn 91, Issue 7, 2012, Pages 794-801

  Koliopoulos, George ^a   Chrelias, Charalambos ^a   Pappas, Asimakis ^a   Makridima, Sofia ^a   Kountouris, Emmanuel ^a   Alepaki, Maria ^a   Spathis, Aris ^a   Stathopoulou, Vicky ^a   Panayiotides, Ioannis ^a   Panagopoulos, Pericles ^a   Karakitsos, Petros ^a   Kassanos, Dimitrios ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cytopathogenic effect; E6 e7 mRNA; Flow cytometry; Self sustained sequence replication; Sensitivity and specificity; Vaginal smears; Viral

Indexed keywords

MESSENGER RNA; VIRUS RNA;

ARTICLE; COLPOSCOPY; COMPARATIVE STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEIC ACID SEQUENCE BASED AMPLIFICATION; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLOW CYTOMETRY; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; REPRESSOR PROTEINS; RNA, MESSENGER; SELF-SUSTAINED SEQUENCE REPLICATION; SENSITIVITY AND SPECIFICITY; TRIAGE; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 84862881127     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2012.01414.x     Document Type: Article

References (22)

1. Solomon D, Schiffman M, Tarone R. ALTS Study group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93:293-9.
2. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst. 2000;92:397-402.
3. Arbyn M, Sasieni P, Meijer CLM, Clavel C, Koliopoulos G, Dillner J. Clinical applications of HPV testing: a summary of meta-analyses. Vaccine. 2006;24S3:78-89.
4. Arbyn, M, Buntinx, F, Van Ranst, M, Paraskevaidis, E, Martin-Hirsch, P, Dillner, J. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J. Natl. Cancer Inst. 2004;96:280-93.
5. Yugawa T, Kiyono T. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7oncoproteins. Rev Med Virol. 2009;19:97-113.
6. Burger EA, Kornør H, Klemp M, Lauvrak V, Kristiansen IS. HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review. Gynecol Oncol. 2011;120:430-8.
7. Cattani P, Zannoni GF, Ricci C, D'Onghia S, Trivellizzi IN, Di Franco A, et al. Clinical performance of human papillomavirus E6 and E7mRNA testing for high-grade lesions of the cervix. J Clin Microbiol. 2009;47:3895-901.
8. Jeronimo J, Schiffman M. Colposcopy at a crossroads. Am J Obstet Gynecol. 2006;195:349-53.
9. Koliopoulos G, Arbyn M, Martin-Hirsch P, Kyrgiou M, PrendivilleW, Paraskevaidis E. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol Oncol. 2007;104:232-46.
10. Tsoumpou I, Valasoulis G, Founta C, Kyrgiou M, Nasioutziki M, Daponte A, et al. High-risk human papillomavirus DNA test and p16(INK4a) in the triage of LSIL: a prospective diagnostic study. Gynecol Oncol. 2011;121:49-53.
11. Zuchna C, Hager M, Tringler B, Georgoulopoulos A, Ciresa-Koenig A, et al. (2010) Diagnostic accuracy of guided cervical biopsies: a prospective multicenter study comparing the histopathology of simultaneous biopsy and cone specimen. Am J Obstet Gynecol. 203:321-326.
12. Wentzensen N, Gravitt PE, Solomon D,Wheeler CM, Philip E. A Study of Amplicor HPV DNA Detection in the ASCUS-LSIL Triage Study. Castle Cancer Epidemiol Biomarkers Prev. 2009;18:1341-9.
13. Jordan J, Martin-Hirsch P, Arbyn M, Schenck U, Baldauf JJ, Da Silva D, et al. European guidelines for clinical management of abnormal cervical cytology, part 2. Cytopathology. 2009;20:5-16.
14. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J LowGenit Tract Dis. 2007;11:223-39.
15. Castle PE, Schiffman M, Wheeler CM, Solomon D. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol. 2009;113:18-25.
16. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, PrendivilleW, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 2006;367:489-98.
17. Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P, et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. Br Med J. 2008;337:a1284.
18. Sorbye SW, Fismen S, Gutteberg T, Mortensen ES. Triage of women with minor cervical lesions: data suggesting a 'test and treat' approach for HPV E6/ E7 mRNA testing. PLoS One. 2010;5:e12724.
19. Coquillard G, Palao B, Patterson BK. Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA. Gynecol Oncol. 2011;120:89-93.
20. Sorbye SW, Fismen S, Gutteberg TJ, Mortensen ES. HPV mRNA test in women with minor cervical lesions: experience of the University Hospital of North Norway. J Virol Methods.2010;169:219-22.
21. Sørbye SW, Arbyn M, Fismen S, Gutteberg TJ, Mortensen ES. HPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy. PLoS One. 2011;6:e26022.
22. Gage JC, Schiffman M, Solomon D, Wheeler CM, Castle PE. Comparison of measurements of human papillomavirus persistence for post colposcopic surveillance for cervical precancerous lesions. Cancer Epidemiol Biomarkers Prev. 2010;19:1668-74.